805 research outputs found
Correction to: Comparison of glycyrrhizin content in 25 major kinds of Kampo extracts containing Glycyrrhizae Radix used clinically in Japan
No full textThe article Comparison of glycyrrhizin content in 25 major kinds of Kampo extracts containing Glycyrrhizae Radix used clinically in Japan, written by Mitsuhiko Nose, Momoka Tada, Rika Kojima, Kumiko Nagata, Shinsuke Hisaka, Sayaka Masada, Masato Homma and Takashi Hakamatsuka, was originally published Online First without open access. After publication in volume 71, issue 4, page 711–722 the author decided to opt for Open Choice and to make the article an open access publication. Therefore, the copyright of the article has been changed to © The Author(s) 2018 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</jats:p
1. He-film Kosteritz-Touless phase transitionとP_sのuniversal jumpについて(筑波大学物理学研究科物理学専攻,修士論文アブストラクト(1979年度))
No full textこの論文は国立情報学研究所の電子図書館事業により電子化されました
Fabrication of monodispersed spherical thermosensitive gels and their dynamic behavior in aqueous polymeric solutions with temperature gradient
No full text博士論文本文Full 以下に掲載：Applied Sciences 10(6)-2016 2020. MDPI. 共著者：Sisworo Raden Rinova, Hasegawa Masato, Nakashima Kousuke, Norimatsu Yu, Tada Yuki
<em>Tada</em>, <em>kada</em>, <em>šiada</em>, <em>andai</em>, <em>idant</em>
No full textLITH. TADA, KADA, ŠIADA, ANDAI, IDANTSummaryThe author discusses the origin of the Lithuanian forms tada, kada, šiada; kadai, kadaise kadan, kadangi; andai; idant etc. and concludes the following:The Lithuanian compounds of this type are related to the corresponding Slavic and Indo-Iranian compounds. The element -d- in the Lithuanian compounds belongs to the stems of the demonstrative pronoun *do/*de (OP din, dīgi) as the same element in OInd. tadā́, kadā́, yadā́. The element -g- in the Slavic and Baltic compounds (OCS togda, Russ. тогда, OPol. tegdy, Czech, tehda etc., Lith. tagačiaus, tagatės, Latv. tagad) could be reconstructed from the particle *go (i. e. the one related to Slavic же, OInd. gh, ha, Gk. γε, γα, Goth, -k in mi-k "me")
sj-docx-2-tam-10.1177_17588359221119538 – Supplemental material for Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma
No full textSupplemental material, sj-docx-2-tam-10.1177_17588359221119538 for Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma by Daisuke Kawakita, Toshitaka Nagao, Hideaki Takahashi, Satoshi Kano, Yoshitaka Honma, Hideaki Hirai, Natsuki Saigusa, Kohei Akazawa, Kaori Tani, Hiroya Ojiri, Kiyoaki Tsukahara, Hiroyuki Ozawa, Kenji Okami, Takahito Kondo, Takafumi Togashi, Chihiro Fushimi, Tomotaka Shimura, Akira Shimizu, Isaku Okamoto, Takuro Okada, Yorihisa Imanishi, Yoshihiro Watanabe, Kuninori Otsuka, Akihiro Sakai, Koji Ebisumoto, Yuichiro Sato, Keisuke Yamazaki, Yushi Ueki, Toyoyuki Hanazawa, Yuki Saito, Mizuo Ando, Takashi Matsuki, Masato Nakaguro, Yukiko Sato, Makoto Urano, Yoshitaka Utsumi, Shinji Kohsaka, Takashi Saotome and Yuichiro Tada in Therapeutic Advances in Medical Oncology</p
sj-docx-1-tam-10.1177_17588359221119538 – Supplemental material for Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma
No full textSupplemental material, sj-docx-1-tam-10.1177_17588359221119538 for Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma by Daisuke Kawakita, Toshitaka Nagao, Hideaki Takahashi, Satoshi Kano, Yoshitaka Honma, Hideaki Hirai, Natsuki Saigusa, Kohei Akazawa, Kaori Tani, Hiroya Ojiri, Kiyoaki Tsukahara, Hiroyuki Ozawa, Kenji Okami, Takahito Kondo, Takafumi Togashi, Chihiro Fushimi, Tomotaka Shimura, Akira Shimizu, Isaku Okamoto, Takuro Okada, Yorihisa Imanishi, Yoshihiro Watanabe, Kuninori Otsuka, Akihiro Sakai, Koji Ebisumoto, Yuichiro Sato, Keisuke Yamazaki, Yushi Ueki, Toyoyuki Hanazawa, Yuki Saito, Mizuo Ando, Takashi Matsuki, Masato Nakaguro, Yukiko Sato, Makoto Urano, Yoshitaka Utsumi, Shinji Kohsaka, Takashi Saotome and Yuichiro Tada in Therapeutic Advances in Medical Oncology</p
sj-docx-3-tam-10.1177_17588359221119538 – Supplemental material for Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma
No full textSupplemental material, sj-docx-3-tam-10.1177_17588359221119538 for Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma by Daisuke Kawakita, Toshitaka Nagao, Hideaki Takahashi, Satoshi Kano, Yoshitaka Honma, Hideaki Hirai, Natsuki Saigusa, Kohei Akazawa, Kaori Tani, Hiroya Ojiri, Kiyoaki Tsukahara, Hiroyuki Ozawa, Kenji Okami, Takahito Kondo, Takafumi Togashi, Chihiro Fushimi, Tomotaka Shimura, Akira Shimizu, Isaku Okamoto, Takuro Okada, Yorihisa Imanishi, Yoshihiro Watanabe, Kuninori Otsuka, Akihiro Sakai, Koji Ebisumoto, Yuichiro Sato, Keisuke Yamazaki, Yushi Ueki, Toyoyuki Hanazawa, Yuki Saito, Mizuo Ando, Takashi Matsuki, Masato Nakaguro, Yukiko Sato, Makoto Urano, Yoshitaka Utsumi, Shinji Kohsaka, Takashi Saotome and Yuichiro Tada in Therapeutic Advances in Medical Oncology</p
sj-docx-4-tam-10.1177_17588359221119538 – Supplemental material for Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma
No full textSupplemental material, sj-docx-4-tam-10.1177_17588359221119538 for Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma by Daisuke Kawakita, Toshitaka Nagao, Hideaki Takahashi, Satoshi Kano, Yoshitaka Honma, Hideaki Hirai, Natsuki Saigusa, Kohei Akazawa, Kaori Tani, Hiroya Ojiri, Kiyoaki Tsukahara, Hiroyuki Ozawa, Kenji Okami, Takahito Kondo, Takafumi Togashi, Chihiro Fushimi, Tomotaka Shimura, Akira Shimizu, Isaku Okamoto, Takuro Okada, Yorihisa Imanishi, Yoshihiro Watanabe, Kuninori Otsuka, Akihiro Sakai, Koji Ebisumoto, Yuichiro Sato, Keisuke Yamazaki, Yushi Ueki, Toyoyuki Hanazawa, Yuki Saito, Mizuo Ando, Takashi Matsuki, Masato Nakaguro, Yukiko Sato, Makoto Urano, Yoshitaka Utsumi, Shinji Kohsaka, Takashi Saotome and Yuichiro Tada in Therapeutic Advances in Medical Oncology</p
The role of cyclic nucleotide on fetal and neonantal erythropoiesis
No full textFor the purpose to reveal the changes in stimulatory
effect of dibutyryl-cyclic- AMP on erythropoiesis during ontogenetic development, the author studied syntheses of DNA, RNA and protein of erythroid cells in fetal liver, neonatal and adult bone marrows of rats. In the bone marrow of neonatal animals erythropoiesis was stimulated by the intraperitoneal injection of cyclic nucleotide with
enhanced DNA, RNA and protein syntheses of erythroid cells. Enhancing effect of dibutyryl-c-AMP on the erythropoiesis decreased gradually with advance of neonatal days. Autoradiographic observations revealed that in erythoid cells isolated from fetal liver and neonatal
bone marrows, DNA-, RNA- and protein-snythesis was markedly
stimulated by incubating with cyclic nucleotide, but not in those from adult bone marrow. Discussion was made on the changes in the regulatory mechanism of erythropoiesis according to the transition of hematopoietic organs during development.</p
Friction force microscopy using silicon cantilevers covered with organic monolayers via silicon–carbon covalent bonds
No full text- …
